Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine ...

A new pancreatic cancer vaccine has appeared to slow disease progression and increase survival for patients in an early trial ...

A new vaccine designed to combat cancer cells in patients with colorectal and pancreatic cancer showed promising results in ...

A groundbreaking pancreatic cancer vaccine shows promise in preventing recurrence, offering new hope for one of the deadliest cancers with historically low survival rates.

Black and Hispanic people are more likely to be diagnosed with pancreatic cancer and more likely to die from it. Now, one drug may help fix this.

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about heart attack warning signs, a pancreatic cancer vaccine showing promise ...

Experimental vaccines shrouded in controversy and targeted by health secretary Robert F Kennedy Jr may protect against one of ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

The vaccine ELI-002 2P showed favorable relapse-free survival and overall survival in patients with pancreatic and colorectal ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...

New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.

Bayer announces deal with Kumquat for a pancreatic cancer KRAS inhibitor, plus, promising mRNA vaccine research emerges from ...